Mark A Birrell (Mark Birrell)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 3

Top Topics

Chronic Obstructive Pulmonary Disease

Epithelial Mesenchymal Transition

Top Venues

American journal of respiratory and critical care medicine

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Magnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, Susanne Berglund, Antonio Piras, Parmis Blomgran, Anders Cavallin, Mia Collins, Göran Dahl, Bilel Dekkak, Therese Ericsson, Niklas Hagberg, Ann Aurell Holmberg, Agnes Leffler, Anders J Lundqvist, Thomais Markou, James Pinkerton, Lars Rönnblom, Stacey Siu, Vanessa Taylor, Tiiu Wennberg, Dimitrios Zervas, Arian Dominic John Laurence, Suman Mitra, Maria G Belvisi, Mark A Birrell, Annika Borde
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma. Drug design, development and therapy 16 (2022)
Declan F Doherty, Sridesh Nath, Justin Poon, Robert F Foronjy, Michael Ohlmeyer, Abdoulaye J Dabo, Matthias A Salathe, Mark A Birrell, Maria G Belvisi, Nathalie Baumlin, Michael D Kim, Sinéad Weldon, Clifford C Taggart, Patrick Geraghty
Protein Phosphatase 2A Reduces Cigarette Smoke-induced Cathepsin S and Loss of Lung Function. American journal of respiratory and critical care medicine 200 (1) (2020)
Maria G Belvisi, Mark A Birrell, Michael A Wortley, Sarah A Maher, Imran Satia, Huda Badri, Kimberley Holt, Patrick Round, Lorcan McGarvey, John Ford, Jaclyn Ann Smith
XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough. American journal of respiratory and critical care medicine 196 (10) (2017)